Follow The Filings

SIBN Si-Bone Inc.

Health Care, filed as SI-BONE INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.0%
  • $13M
  • 1 add

In 2026 Q2 First Eagle Investment Management added to Si-Bone.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (First Eagle Investment Management). Not free-float ownership.

  1. First Eagle Investment Manage... Add 0.02%

Who owns SIBN

Sorted by value, long equity only, as of 2026 Q2.

History
First Eagle Investment Management 0.02%, was 0.01% Add +20.3% 768,941 $13M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by SIBN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SIBN insider trades
  • None no insider bought on the open market
  • $161K sold by 2 insiders outside a trading plan
  • $7.5M sold by 4 insiders under 10b5-1 plans
  1. Laura Francis CEO
    Planned sale
    $762K 38,006 shares at $20.05 9.1% of stake
    Traded Oct 12 Filed Oct 14
    ↗
  2. Anshul Maheshwari Chief Op & Financial Officer
    Planned sale
    $34K 1,731 shares at $19.50 0.8% of stake
    Traded Oct 5 Filed Oct 6
    ↗
  3. Jeffrey W Dunn Director
    Planned sale
    $369K 20,000 shares at $18.47 56% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  4. Jeffrey W Dunn Director
    Planned sale
    $378K 20,000 shares at $18.91 56% of stake
    Traded Sep 1 Filed Sep 3
    ↗
  5. Anshul Maheshwari Chief Op & Financial Officer
    Planned sale
    $234K 11,636 shares at $20.11 5% of stake
    Traded Aug 24 Filed Aug 26
    ↗
  6. Laura Francis CEO
    Planned sale
    $523K 25,972 shares at $20.12 8.2% of stake
    Traded Aug 24 Filed Aug 26
    ↗
  7. Anshul Maheshwari Chief Op & Financial Officer
    Planned sale
    $337K 16,975 shares at $19.86 6.7% of stake
    Traded Aug 19–21 Filed Aug 21
    ↗
  8. Laura Francis CEO
    Planned sale
    $1.1M 55,807 shares at $19.50 15% of stake
    Traded Aug 20–21 Filed Aug 21
    ↗
  9. Jeffrey W Dunn Director
    Planned sale
    $369K 20,000 shares at $18.46 56% of stake
    Traded Aug 3 Filed Aug 5
    ↗
  10. Timothy E Davis Jr. Director
    Sale
    $104K 7,280 shares at $14.31 10% of stake
    Traded May 28–29 Filed Jun 1
    ↗
  11. Mika Nishimura Director
    Sale
    $57K 4,100 shares at $13.83 11% of stake
    Traded Mar 12 Filed Mar 13
    ↗
  12. Jeffrey W Dunn Director
    Planned sale
    $426K 20,000 shares at $21.28 20% of stake
    Traded Jan 8 Filed Jan 12
    ↗
  13. Anshul Maheshwari CFO
    Planned sale
    $30K 1,552 shares at $19.63 0.9% of stake
    Traded Jan 2 Filed Jan 6
    ↗
  14. Anshul Maheshwari CFO
    Planned sale
    $374K 18,542 shares at $20.15 9.1% of stake
    Traded Dec 18, 2025 Filed Dec 19, 2025
    ↗
  15. Michael A. Pisetsky SVP, Ops & Adm/Chief Legal Ofr
    Planned sale
    $395K 19,600 shares at $20.15 7.8% of stake
    Traded Dec 18, 2025 Filed Dec 19, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 77 sales to cover taxes, 15 stock grants, and 9 option exercises.

SEC filings

Recent issuer filings from EDGAR, 12 shown.

Filed Form Detail Links
8-K 1.01,2.03,8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,2.03,5.07,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $138.89M $167.18M $200.92M
Gross profit $109.42M $132.12M $159.88M
Gross margin * 78.8% 79.0% 79.6%
Net income -$43.34M -$30.91M -$18.9M
Net margin * -31.2% -18.5% -9.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $211.39M $207.78M $216.12M
Total non-current assets * $19.03M $22.66M $22.44M
Total assets $230.42M $230.44M $238.56M
Total current liabilities $23.46M $27.13M $25.28M
Total non-current liabilities * $37.59M $36.34M $35.74M
Total equity $169.38M $166.96M $177.53M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$18.71M -$12.42M -$0.675M
Cash from investing -$59.8M $12.62M $4.16M
Cash from financing $90.93M $1.96M $3.38M
Net change in cash $12.55M $1.68M $7.29M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.